Valuation: Terumo Corporation

Market Cap 3,193B 19.5B 17.12B 15.93B 14.62B 27.46B 1,881B 27.9B 187B 73.75B 922B 73.2B 71.65B P/E 2027 *
19.1x
P/E 2028 * 17.2x
Enterprise Value 3,269B 19.96B 17.53B 16.31B 14.97B 28.11B 1,926B 28.56B 192B 75.51B 944B 74.95B 73.35B EV / Sales 2027 *
2.64x
EV / Sales 2028 * 2.44x
Free-Float
97.07%
Yield 2027 *
1.65%
Yield 2028 * 1.84%
1 day+0.30%
1 week-4.54%
Current month-3.11%
1 month-1.32%
3 months+5.28%
6 months+0.23%
Current year-4.65%
1 week 2,133
Extreme 2133
2,296
1 month 2,133
Extreme 2133
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%-4.54%-16.36%-2.68% 19.5B
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average +0.52%-2.47%-3.27%-1.36% 56.34B
Weighted average by Cap. +1.25%-0.54%-7.16%+0.98%

Financials

2027 *2028 *
Net sales 1,239B 7.57B 6.64B 6.18B 5.67B 10.66B 730B 10.82B 72.68B 28.62B 358B 28.4B 27.8B 1,318B 8.05B 7.07B 6.57B 6.03B 11.33B 776B 11.51B 77.3B 30.44B 381B 30.21B 29.57B
Net income 166B 1.01B 889M 827M 759M 1.43B 97.64B 1.45B 9.72B 3.83B 47.88B 3.8B 3.72B 185B 1.13B 993M 924M 848M 1.59B 109B 1.62B 10.87B 4.28B 53.51B 4.25B 4.16B
Net Debt 75.98B 464M 407M 379M 348M 654M 44.77B 664M 4.46B 1.76B 21.95B 1.74B 1.71B 16.78B 102M 90M 83.72M 76.84M 144M 9.89B 147M 985M 388M 4.85B 385M 377M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
24/07/26 ¥2,164.50 +0.30% 2,693,400
23/07/26 ¥2,158.00 -1.86% 3,500,500
22/07/26 ¥2,199.00 -1.85% 4,119,100
21/07/26 ¥2,240.50 -1.19% 4,257,300
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,164.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+36.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock